* Public Call * Direct Hiring, The Following Strategic Health Inputs: Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Cannabidiol Prati -Donaduzzi 200 Mg/Ml, 30 Ml, Medicinal Extract Active Principle: Cannabis Sativa, Composition: Cannabidiol Cbd, Concentration: 47.5Mg/Ml, Pharmaceutical Form: Solution Oral - Drops Canaabidiol Mantecorp Farmasa 79.14 Mg/Ml, 30 Ml, Ribocyclibe Composition: Succinato, Concentration: 200Mg, Fultestrantra Dosage: 50Mg/Ml, Pharmaceutical Form: Injectable Solution, Additional Characteristics 1: Filled Syringe, Insulin Type: Degludeca, Concentration: 100Ui/Ml, Pharmaceutical Form: Solution Injectable, Additional Characteristic: With Applicator, Larotrectinib Composition: Sulfate, Concentration: 20Mg/Ml, Pharmaceutical Form: Oral Solution, Radiopharmaceutical - Radioisotope Name: 223Ra - Radio Chloride, Radioactive Concentration: 1000 To 1100 Kbq/Ml, Pharmaceutical Form: Injectable Solution, Pasireotide Composition, Concentration: Concentration: Concentration: Concentration: Concentration 0.6Mg/Ml, Pharmaceutical Form: Injectable Solution.

Ministerio da Saude - Departamento de Logistica em Saude - Coordenacao-Geral de Licitacoes e Contratos de Insumos Estrategicos para Saude Brazil has Released a tender for * Public Call * Direct Hiring, The Following Strategic Health Inputs: Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Cannabidiol Prati -Donaduzzi 200 Mg/Ml, 30 Ml, Medicinal Extract Active Principle: Cannabis Sativa, Composition: Cannabidiol Cbd, Concentration: 47.5Mg/Ml, Pharmaceutical Form: Solution Oral - Drops Canaabidiol Mantecorp Farmasa 79.14 Mg/Ml, 30 Ml, Ribocyclibe Composition: Succinato, Concentration: 200Mg, Fultestrantra Dosage: 50Mg/Ml, Pharmaceutical Form: Injectable Solution, Additional Characteristics 1: Filled Syringe, Insulin Type: Degludeca, Concentration: 100Ui/Ml, Pharmaceutical Form: Solution Injectable, Additional Characteristic: With Applicator, Larotrectinib Composition: Sulfate, Concentration: 20Mg/Ml, Pharmaceutical Form: Oral Solution, Radiopharmaceutical - Radioisotope Name: 223Ra - Radio Chloride, Radioactive Concentration: 1000 To 1100 Kbq/Ml, Pharmaceutical Form: Injectable Solution, Pasireotide Composition, Concentration: Concentration: Concentration: Concentration: Concentration 0.6Mg/Ml, Pharmaceutical Form: Injectable Solution. in Pharmaceuticals. The tender was released on May 30, 2025.

Country - Brazil

Summary - * Public Call * Direct Hiring, The Following Strategic Health Inputs: Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Cannabidiol Prati -Donaduzzi 200 Mg/Ml, 30 Ml, Medicinal Extract Active Principle: Cannabis Sativa, Composition: Cannabidiol Cbd, Concentration: 47.5Mg/Ml, Pharmaceutical Form: Solution Oral - Drops Canaabidiol Mantecorp Farmasa 79.14 Mg/Ml, 30 Ml, Ribocyclibe Composition: Succinato, Concentration: 200Mg, Fultestrantra Dosage: 50Mg/Ml, Pharmaceutical Form: Injectable Solution, Additional Characteristics 1: Filled Syringe, Insulin Type: Degludeca, Concentration: 100Ui/Ml, Pharmaceutical Form: Solution Injectable, Additional Characteristic: With Applicator, Larotrectinib Composition: Sulfate, Concentration: 20Mg/Ml, Pharmaceutical Form: Oral Solution, Radiopharmaceutical - Radioisotope Name: 223Ra - Radio Chloride, Radioactive Concentration: 1000 To 1100 Kbq/Ml, Pharmaceutical Form: Injectable Solution, Pasireotide Composition, Concentration: Concentration: Concentration: Concentration: Concentration 0.6Mg/Ml, Pharmaceutical Form: Injectable Solution.

Deadline - Jun 06, 2025

GT reference number - 110013491

Product classification - Medicinal products for the alimentary tract and metabolism